The IBD Disability Index should become a Major Secondary Endpoint in Clinical Practice and in Clinical Trials.

J Crohns Colitis

Public Health, Epidemiology and Economic Health, EPIMAD registry, Regional House of Clinical Research, University Hospital, 59000, Lille, France.

Published: December 2016

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjw156DOI Listing

Publication Analysis

Top Keywords

ibd disability
4
disability major
4
major secondary
4
secondary endpoint
4
endpoint clinical
4
clinical practice
4
practice clinical
4
clinical trials
4
clinical
2
ibd
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!